Michael Balatico

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Tyrosine Kinase

Epidermal Growth Factor Receptor

Top Venues

bioRxiv : the preprint server for biology

This page only lists publications with an associated author ORCID identifier.

Publications

Eric A Smith, Rachel L Belote, Nelly M Cruz, Tarek E Moustafa, Carly A Becker, Amanda Jiang, Shukran Alizada, Tsz Yin Chan, Tori A Seasor, Michael Balatico, Emilio Cortes-Sanchez, David H Lum, John R Hyngstrom, Hanlin Zeng, Dekker C Deacon, Allie H Grossmann, Richard M White, Thomas A Zangle, Robert L Judson
Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironment. bioRxiv : the preprint server for biology (2024)
Eric A Smith, Rachel L Belote, Nelly M Cruz, Tarek E Moustafa, Carly A Becker, Amanda Jiang, Shukran Alizada, Tsz Yin Chan, Tori A Seasor, Michael Balatico, Emilio Cortes-Sanchez, David H Lum, John R Hyngstrom, Hanlin Zeng, Dekker C Deacon, Allie H Grossmann, Richard M White, Thomas A Zangle, Robert L Judson
Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironment. bioRxiv : the preprint server for biology (2024)
Eric A Smith, Rachel L Belote, Nelly M Cruz, Tarek E Moustafa, Carly A Becker, Amanda Jiang, Shukran Alizada, Tsz Yin Chan, Tori A Seasor, Michael Balatico, Emilio Cortes-Sanchez, David H Lum, John R Hyngstrom, Hanlin Zeng, Dekker C Deacon, Allie H Grossmann, Richard M White, Thomas A Zangle, Robert L Judson
Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironment. bioRxiv : the preprint server for biology (2024)
Eric A Smith, Rachel L Belote, Nelly M Cruz, Tarek E Moustafa, Carly A Becker, Amanda Jiang, Shukran Alizada, Tsz Yin Chan, Tori A Seasor, Michael Balatico, Emilio Cortes-Sanchez, David H Lum, John R Hyngstrom, Hanlin Zeng, Dekker C Deacon, Allie H Grossmann, Richard M White, Thomas A Zangle, Robert L Judson
Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironment. bioRxiv : the preprint server for biology (2024)